Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration
Public ClinicalTrials.gov record NCT00100009. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multi-Center, Randomized, Phase II/III Clinical Trial to Study the Effects of Preservative-Free Triamcinolone Acetonide as an Adjunct to Photodynamic Therapy in Participants With Neovascular Age-Related Macular Degeneration
Study identification
- NCT ID
- NCT00100009
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- National Eye Institute (NEI)
- NIH
- Enrollment
- 30 participants
Conditions and interventions
Conditions
Interventions
- TAC-PF Drug
- Triamcinolone Acetonide Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 8, 2004
- Primary completion
- Not listed
- Completion
- Dec 19, 2006
- Last update posted
- Jul 1, 2017
2004 – 2006
United States locations
- U.S. sites
- 23
- U.S. states
- 16
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retina Associates Southwest (RASTA) | Tucson | Arizona | — | — |
| Doheny Eye Institute | Los Angeles | California | — | — |
| Bascom Palmer Eye Institute | Miami | Florida | — | — |
| Central Florida Retina (CFROL) | Orlando | Florida | — | — |
| Retina Associates of Florida | Tampa | Florida | — | — |
| Midwest Eye Institute | Indianapolis | Indiana | — | — |
| Elman Retina Group, P.A. - Baltimore (ERGBM) | Baltimore | Maryland | 21237 | — |
| National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland | 20892 | — |
| Elman Retina Group, P.A. - Pikesville (ERGPM) | Pikesville | Maryland | 21208 | — |
| University of Michigan | Ann Arbor | Michigan | 48109-0624 | — |
| VitreoRetinal Surgery (VRSMN) Center | Minneapolis | Minnesota | — | — |
| Cornell University | New York | New York | 10021-4872 | — |
| Duke University Eye Center (DUENC) | Durham | North Carolina | 27710 | — |
| Dean McGee Eye Institute (DMEIO) | Oklahoma City | Oklahoma | — | — |
| Casey Eye Institute-Portland, OR (CEIPO) | Portland | Oregon | 97239 | — |
| Retina Northwest (RNWPO) | Portland | Oregon | — | — |
| Wills Eye Hospital | Philadelphia | Pennsylvania | — | — |
| Southeastern Retina Associates (SRAKT) | Knoxville | Tennessee | — | — |
| Vanderbilt University | Nashville | Tennessee | 37232 | — |
| Texas Retina Associates | Arlington | Texas | — | — |
| Texas Retina Associates | Dallas | Texas | — | — |
| Retina Group of Washington - Fairfax (RGWFF) | Fairfax | Virginia | 22031 | — |
| University of Wisconsin | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00100009, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 1, 2017 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00100009 live on ClinicalTrials.gov.